UF Biostatistician at the Forefront of Groundbreaking Childhood Leukemia Drug Trial
A clinical trial co-designed by UF researcher found that adding blinatumomab to chemotherapy significantly reduced relapse risk in children with acute lymphoblastic leukemia, marking a major breakthrough in treatment.
Research Snapshot: Researchers Identify Genes That Predict Pediatric AML Outcomes
UF researchers identified genes that were associated with resistance or sensitivity to chemotherapy and linked these with patients’ treatment outcomes.
Targeting Protein Restores Aging Blood Cells, UF Researchers Find
UF researchers have discovered a way to prevent chronic inflammation that harms blood stem cells in the bone marrow, weakens the immune system, and reduces chemotherapy effectiveness.
